{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T23:12:45Z","timestamp":1767827565756,"version":"3.49.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,12]],"date-time":"2014-11-12T00:00:00Z","timestamp":1415750400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s10928-014-9399-4","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T15:10:50Z","timestamp":1415977850000},"page":"79-96","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Modeling energy intake by adding homeostatic feedback and drug intervention"],"prefix":"10.1007","volume":"42","author":[{"given":"Peter","family":"Gennemark","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Hjorth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Gabrielsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,12]]},"reference":[{"key":"9399_CR1","volume-title":"The pharmacological basis of therapeutics","author":"LS Goodman","year":"1996","unstructured":"Goodman LS, Gilman A (1996) The pharmacological basis of therapeutics, 11th edn. McGrawHill, New York","edition":"11"},{"issue":"5\u20136","key":"9399_CR2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s10928-005-0087-2","volume":"32","author":"B S\u00e4llstr\u00f6m","year":"2005","unstructured":"S\u00e4llstr\u00f6m B, Visser SA, Forsberg T, Peletier LA, Ericson AC, Gabrielsson J (2005) A pharmacodynamic turnover model capturing asymmetric circadian baselines of body temperature, heart rate and blood pressure in rats: challenges in terms of tolerance and animal handling effects. J Pharmacokinet Pharmacodyn 32(5\u20136):835\u2013859","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"3","key":"9399_CR3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejps.2011.08.005","volume":"44","author":"C Ahlstr\u00f6m","year":"2011","unstructured":"Ahlstr\u00f6m C, Peletier LA, Gabrielsson J (2011) Quantitative analysis of rate and extent of tolerance of biomarkers: application to nicotinic acid-induced changes in non-esterified fatty acids in rats. Eur J Pharm Sci 44(3):250\u2013264","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"9399_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10928-010-9172-2","volume":"38","author":"C Ahlstr\u00f6m","year":"2011","unstructured":"Ahlstr\u00f6m C, Peletier LA, Jansson-L\u00f6fmark R, Gabrielsson J (2011) Feedback modeling of non-esterified fatty acids in rats after nicotinic acid infusions. J Pharmacokinet Pharmacodyn 38(1):1\u201324","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"6","key":"9399_CR5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10928-013-9335-z","volume":"40","author":"C Ahlstr\u00f6m","year":"2013","unstructured":"Ahlstr\u00f6m C, Kroon T, Peletier LA, Gabrielsson J (2013) Feedback modeling of non-esterified fatty acids in obese Zucker rats after nicotinic acid infusions. J Pharmacokinet Pharmacodyn 40(6):623\u2013638","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"4","key":"9399_CR6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10928-013-9325-1","volume":"40","author":"C Ahlstr\u00f6m","year":"2013","unstructured":"Ahlstr\u00f6m C, Peletier LA, Gabrielsson J (2013) Challenges of a mechanistic feedback model describing nicotinic acid-induced changes in non-esterified fatty acids in rats. J Pharmacokinet Pharmacodyn 40(4):497\u2013512","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"1","key":"9399_CR7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2337\/diacare.27.1.155","volume":"27","author":"JS Torgerson","year":"2004","unstructured":"Torgerson JS, Hauptman J, Boldrin MN, Sj\u00f6str\u00f6m L (2004) XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 27(1):155\u2013161","journal-title":"Diabetes Care"},{"issue":"1","key":"9399_CR8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4093\/dmj.2012.36.1.13","volume":"36","author":"JG Kang","year":"2012","unstructured":"Kang JG, Park CY (2012) Anti-obesity drugs: a review about their effects and safety. Diabetes Metab J 36(1):13\u201325","journal-title":"Diabetes Metab J"},{"key":"9399_CR9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF02353781","volume":"23","author":"WJ Jusko","year":"1995","unstructured":"Jusko WJ, Ko HC, Ebling WF (1995) Convergence of direct and indirect pharmacodynamic response models. J Pharmacokinet Biopharm 23:5\u20138","journal-title":"J Pharmacokinet Biopharm"},{"issue":"9","key":"9399_CR10","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1007\/s11095-005-5882-3","volume":"22","author":"M Danhof","year":"2005","unstructured":"Danhof M, Alvan G, Dahl SG, Kuhlmann J, Paintaud G (2005) Mechanism-based pharmacokinetic-pharmacodynamic modeling\u2014a new classification of biomarkers. Pharm Res 22(9):1432\u20131437","journal-title":"Pharm Res"},{"issue":"11 Suppl 1","key":"9399_CR11","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1210\/jc.2008-1630","volume":"93","author":"SC Woods","year":"2008","unstructured":"Woods SC, D\u2019Alessio DA (2008) Central control of body weight and appetite. J Clin Endocrinol Metab 93(11 Suppl 1):S37\u2013S50","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 3","key":"9399_CR12","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1038\/oby.2008.511","volume":"16","author":"NR Lenard","year":"2008","unstructured":"Lenard NR, Berthoud HR (2008) Central and peripheral regulation of food intake and physical activity: pathways and genes. Obesity (Silver Spring) 16(Suppl 3):S11\u2013S22","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"9399_CR13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pharmthera.2007.09.001","volume":"117","author":"JD Fernstrom","year":"2008","unstructured":"Fernstrom JD, Choi S (2008) The development of tolerance to drugs that suppress food intake. Pharmacol Ther 117(1):105\u2013122","journal-title":"Pharmacol Ther"},{"issue":"1","key":"9399_CR14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cmet.2008.11.005","volume":"9","author":"J Tam","year":"2009","unstructured":"Tam J, Fukumura D, Jain RK (2009) A mathematical model of murine metabolic regulation by leptin: energy balance and defense of a stable body weight. Cell Metab 9(1):52\u201363","journal-title":"Cell Metab"},{"issue":"6","key":"9399_CR15","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1242\/dmm.008698","volume":"4","author":"JR Speakman","year":"2011","unstructured":"Speakman JR, Levitsky DA, Allison DB, Bray MS, de Castro JM, Clegg DJ, Clapham JC, Dulloo AG, Gruer L, Haw S, Hebebrand J, Hetherington MM, Higgs S, Jebb SA, Loos RJ, Luckman S, Luke A, Mohammed-Ali V, O\u2019Rahilly S, Pereira M, Perusse L, Robinson TN, Rolls B, Symonds ME, Westerterp-Plantenga MS (2011) Set points, settling points and some alternative models: theoretical options to understand how genes and environments combine to regulate body adiposity. Dis Model Mech 4(6):733\u2013745","journal-title":"Dis Model Mech"},{"issue":"6","key":"9399_CR16","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/ajcn\/79.6.946","volume":"79","author":"C Graaf de","year":"2004","unstructured":"de Graaf C, Blom WA, Smeets PA, Stafleu A, Hendriks HF (2004) Biomarkers of satiation and satiety. Am J Clin Nutr 79(6):946\u2013961","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"9399_CR17","doi-asserted-by":"crossref","first-page":"E1576","DOI":"10.1152\/ajpendo.00058.2012","volume":"302","author":"R Reidelberger","year":"2012","unstructured":"Reidelberger R, Haver A, Chelikani PK, Apenteng B, Perriotte-Olson C, Anders K, Steenson S, Blevins JE (2012) Effects of leptin replacement alone and with exendin-4 on food intake and weight regain in weight-reduced diet-induced obese rats. Am J Physiol Endocrinol Metab 302(12):E1576\u2013E1585","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"9399_CR18","doi-asserted-by":"crossref","DOI":"10.5749\/j.ctv9b2tqv","volume-title":"The biology of human starvation","author":"A Keys","year":"1950","unstructured":"Keys A, Brozek J, Henschel A, Mickelsen O, Taylor HL (1950) The biology of human starvation. University of Minnesota Press, Minneapolis"},{"issue":"3","key":"9399_CR19","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ajcn\/65.3.717","volume":"65","author":"AG Dulloo","year":"1997","unstructured":"Dulloo AG, Jacquet J, Girardier L (1997) Poststarvation hyperphagia and body fat overshooting in humans: a role for feedback signals from lean and fat tissues. Am J Clin Nutr 65(3):717\u2013723","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"9399_CR20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0031-9384(96)00510-0","volume":"61","author":"K Inoue","year":"1997","unstructured":"Inoue K, Kiriike N, Fujisaki Y, Kurioka M, Yamagami S (1997) Effects of fluvoxamine on food intake during rebound hyperphagia in rats. Physiol Behav 61(4):603\u2013608","journal-title":"Physiol Behav"},{"key":"9399_CR21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainres.2009.11.075","volume":"1313","author":"N Lauzurica","year":"2010","unstructured":"Lauzurica N, Garca-Garca L, Pinto S, Fuentes JA, Delgado M (2010) Changes in NPY and POMC, but not serotonin transporter, following a restricted feeding\/repletion protocol in rats. Brain Res 1313:103\u2013112","journal-title":"Brain Res"},{"issue":"2","key":"9399_CR22","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2337\/db12-0598","volume":"62","author":"P Kievit","year":"2012","unstructured":"Kievit P, Halem H, Marks DL, Dong JZ, Glavas MM, Sinnayah P, Pranger L, Cowley MA, Grove KL, Culler MD (2012) Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques. Diabetes 62(2):490\u2013497","journal-title":"Diabetes"},{"issue":"6","key":"9399_CR23","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10928-013-9337-x","volume":"40","author":"P Gennemark","year":"2013","unstructured":"Gennemark P, Jansson-L\u00f6fmark R, Hyberg G, Wigstrand M, Kakol-Palm D, H\u00e5kansson P, Hovdal D, Brodin P, Fritsch-Fredin M, Antonsson M, Ploj K, Gabrielsson J (2013) A modeling approach for compounds affecting body composition. J Pharmacokinet Pharmacodyn 40(6):651\u2013667","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"901","key":"9399_CR24","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1098\/rspb.1953.0009","volume":"140","author":"GC Kennedy","year":"1953","unstructured":"Kennedy GC (1953) The role of depot fat in the hypothalamic control of food intake in the rat. Proc R Soc Lond B Biol Sci 140(901):578\u2013596","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"9399_CR25","volume-title":"Control theory: multivariable and nonlinear methods","author":"T Glad","year":"2000","unstructured":"Glad T, Ljung L (2000) Control theory: multivariable and nonlinear methods. Taylor & Francis, London"},{"issue":"12","key":"9399_CR26","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1210\/jcem.86.12.8111","volume":"86","author":"AM Wren","year":"2001","unstructured":"Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR (2001) Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86(12):5992","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"9399_CR27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10928-011-9194-4","volume":"38","author":"J Fang","year":"2011","unstructured":"Fang J, DuBois DC, He Y, Almon RR, Jusko WJ (2011) Dynamic modeling of methylprednisolone effects on body weight and glucose regulation in rats. J Pharmacokinet Pharmacodyn 38(3):293\u2013316","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"1","key":"9399_CR28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/taap.1993.1052","volume":"119","author":"J Yuan","year":"1993","unstructured":"Yuan J (1993) Modeling blood\/plasma concentrations in dosed feed and dosed drinking water toxicology studies. Toxicol Appl Pharmacol 119(1):131\u2013141","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"9399_CR29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cmet.2010.06.001","volume":"12","author":"KL Ellacott","year":"2010","unstructured":"Ellacott KL, Morton GJ, Woods SC, Tso P, Schwartz MW (2010) Assessment of feeding behavior in laboratory mice. Cell Metab 12(1):10\u201317","journal-title":"Cell Metab"},{"key":"9399_CR30","unstructured":"Gabrielsson J, Weiner D (2010) Pharmacokinetic & pharmacodynamic, data analysis, concepts and applications, 4th edn, 2nd print. Swedish Pharmaceutical Press, Stockholm. ISBN-139789197651004"},{"issue":"3","key":"9399_CR31","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/bjc.1964.55","volume":"18","author":"AK Laird","year":"1964","unstructured":"Laird AK (1964) Dynamics of tumor growth. Br J Cancer 18(3):490\u2013502","journal-title":"Br J Cancer"},{"key":"9399_CR32","first-page":"323","volume":"58","author":"J Magnen Le","year":"1966","unstructured":"Le Magnen J, Tallon S (1966) La priodicit spontane de la prise d\u2019aliments ad libitum du rat blanc. J Physiol (Paris) 58:323\u2013349","journal-title":"J Physiol (Paris)"},{"issue":"4","key":"9399_CR33","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/BF01611170","volume":"32","author":"E Prete Del","year":"1993","unstructured":"Del Prete E, Scharrer E (1993) Influence of age and hepatic branch vagotomy on the night\/day distribution of food intake in rats. Z Ernahrungswiss 32(4):316\u2013320","journal-title":"Z Ernahrungswiss"},{"key":"9399_CR34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF02162161","volume":"10","author":"C Reinsch","year":"1967","unstructured":"Reinsch C (1967) Smoothing by spline functions. Numer Math 10:177\u2013183","journal-title":"Numer Math"},{"issue":"7","key":"9399_CR35","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/sj.bjp.0706807","volume":"148","author":"A Fisas","year":"2006","unstructured":"Fisas A, Codony X, Romero G, Dordal A, Giraldo J, Merc R, Holenz J, Vrang N, Srensen RV, Heal D, Buschmann H, Pauwels PJ (2006) Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats. Br J Pharmacol 148(7):973\u2013983","journal-title":"Br J Pharmacol"},{"issue":"5\u20136","key":"9399_CR36","first-page":"128","volume":"2","author":"MSA Mulla","year":"2010","unstructured":"Mulla MSA, Goyal VK, Jana S, Nirogi R (2010) Safety evaluation of sibutramine in Wistar rats. Afr J Basic Appl Sci 2(5\u20136):128\u2013134","journal-title":"Afr J Basic Appl Sci"},{"issue":"2","key":"9399_CR37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1248\/bpb.33.279","volume":"33","author":"DX Li","year":"2010","unstructured":"Li DX, Jang KY, Kang W, Bae K, Lee MH, Oh YK, Jee JP, Park YJ, Oh DH, Seo YG, Kim YR, Kim JO, Woo JS, Yong CS, Choi HG (2010) Enhanced solubility and bioavailability of sibutramine base by solid dispersion system with aqueous medium. Biol Pharm Bull 33(2):279\u2013284","journal-title":"Biol Pharm Bull"},{"issue":"10","key":"9399_CR38","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/sj.ijo.0801059","volume":"23","author":"DL Hansen","year":"1999","unstructured":"Hansen DL, Toubro S, Stock MJ, Macdonald IA, Astrup A (1999) The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction. Int J Obes Relat Metab Disord 23(10):1016\u20131024","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"4","key":"9399_CR39","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1476-5381.2011.01245.x","volume":"164","author":"SP Vickers","year":"2011","unstructured":"Vickers SP, Jackson HC, Cheetham SC (2011) The utility of animal models to evaluate novel anti-obesity agents. Br J Pharmacol 164(4):1248\u20131262","journal-title":"Br J Pharmacol"},{"key":"9399_CR40","volume-title":"Pharmacodynamics and drug development: perspectives in clinical pharmacology","author":"WA Colburn","year":"1994","unstructured":"Colburn WA, Eldon MA (1994) Simultaneous pharmacokinetic\/pharmacodynamic modeling. In: Butler NR, Sramek JJ, Narang PK (eds) Pharmacodynamics and drug development: perspectives in clinical pharmacology. Wiley, New York"},{"key":"9399_CR41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0022-3565(25)24269-0","volume":"244","author":"HC Porchet","year":"1988","unstructured":"Porchet HC, Benowitz NL, Sheiner LB (1988) Pharmacodynamic model of tolerance: application to nicotine. J Pharmacol Exp Ther 244:231\u2013236","journal-title":"J Pharmacol Exp Ther"},{"key":"9399_CR42","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0022-3565(24)36639-X","volume":"281","author":"DMC Ouellet","year":"1997","unstructured":"Ouellet DMC, Pollack GM (1997) Pharmacodynamics and tolerance development during multiple administrations in rats. J Pharmacol Exp Ther 281:713\u2013720","journal-title":"J Pharmacol Exp Ther"},{"key":"9399_CR43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/ajplegacy.1968.214.1.73","volume":"214","author":"J Urquhart","year":"1968","unstructured":"Urquhart J, Li CC (1968) The dynamics of adrenocortical secretion. Am J Physiol 214:73\u201385","journal-title":"Am J Physiol"},{"key":"9399_CR44","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1749-6632.1969.tb14012.x","volume":"156","author":"J Urquhart","year":"1969","unstructured":"Urquhart J, Li CC (1969) Dynamic testing and modeling of andrecortical secretory function. Ann N Y Acad Sci 156:756\u2013778","journal-title":"Ann N Y Acad Sci"},{"key":"9399_CR45","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/jps.2600820310","volume":"82","author":"P Veng-Pederson","year":"1993","unstructured":"Veng-Pederson P, Modi NB (1993) A system approach to pharmacodynamics. Input-effect control system analysis of central nervous system effect of alfentanil. J Pharm Sci 82:266\u2013272","journal-title":"J Pharm Sci"},{"key":"9399_CR46","first-page":"G581","volume":"262","author":"V Licko","year":"1992","unstructured":"Licko V, Ekblad EB (1992) Dynamics of a metabolic system: what single-action agents reveal about acid secretion. Am J Physiol 262:G581\u2013G592","journal-title":"Am J Physiol"},{"key":"9399_CR47","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1023\/A:1018917522072","volume":"11","author":"JA Bauer","year":"1994","unstructured":"Bauer JA, Fung HL (1994) Pharmacodynamic models of nitroglycerin-induced hemodynamic tolerance in experimental heart failure. Pharm Res 11:816\u2013823","journal-title":"Pharm Res"},{"key":"9399_CR48","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1021\/js980171q","volume":"87","author":"A Sharma","year":"1998","unstructured":"Sharma A, Ebling WF, Jusko WJ (1998) Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena. J Pharm Sci 87:1577\u20131584","journal-title":"J Pharm Sci"},{"key":"9399_CR49","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1088\/0031-9155\/9\/2\/307","volume":"9","author":"E Ackerman","year":"1964","unstructured":"Ackerman E, Rosevear JW, McGuckin WF (1964) A mathematical model of the glucose-tolerance test. Phys Med Biol 9:203\u2013213","journal-title":"Phys Med Biol"},{"key":"9399_CR50","volume-title":"Drug and Tracer kinetics","author":"A Rescigno","year":"1966","unstructured":"Rescigno A, Segre G (1966) Drug and tracer kinetics. Blaisdell Publishing Company, London"},{"key":"9399_CR51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0009-9236(96)90170-8","volume":"60","author":"M Wakelkamp","year":"1996","unstructured":"Wakelkamp M, Alvan G, Gabrielsson J, Paintaud G (1996) Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration. Clin Pharmacol Ther 60:75\u201388","journal-title":"Clin Pharmacol Ther"},{"key":"9399_CR52","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/00912700122009971","volume":"41","author":"H Agers\u00f8","year":"2001","unstructured":"Agers\u00f8 H, Ynddal L, S\u00f8gaard B, Zdravkovic M (2001) Pharmacokinetic and pharmacodynamic modeling of NN703, a growth hormone Secretagogue, after a single po dose to human volunteers. J Clin Pharmacol 41:163\u2013169","journal-title":"J Clin Pharmacol"},{"key":"9399_CR53","doi-asserted-by":"crossref","first-page":"R2059","DOI":"10.1152\/ajpregu.2001.281.6.R2059","volume":"281","author":"KP Zuideveld","year":"2001","unstructured":"Zuideveld KP, Maas HJ, Treijtel N, Hulshof J, van der Graaf PH, Peletier LA, Danhof M (2001) A set-point model with oscillatory behavior predicts the time course of 8-OH-DPAT-induced hypothermia. Am J Physiol Regul Integr Comp Physiol 281:R2059\u2013R2071","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"9399_CR54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clpt.2004.03.006","volume":"76","author":"JJ Lima","year":"2004","unstructured":"Lima JJ, Matsushima N, Kissoon N, Wang J, Sylvester JE, Jusko WJ (2004) Modeling the metabolic effects of terbutaline in \u03b22-adrenergic receptor diplotypes. Clin Pharmacol Ther 76:27\u201337","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"9399_CR55","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10928-006-9008-2","volume":"33","author":"W Winter de","year":"2006","unstructured":"de Winter W, DeJongh J, Post T, Ploeger B, Urquhart R, Moules I, Eckland D, Danhof M (2006) A mechanism-based disease progression model for comparison of long-term effects of pioglitazone, metformin and gliclazide on disease processes underlying type 2 diabetes mellitus. J Pharmacokinet Pharmacodyn 33(3):313\u2013343","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"1362","key":"9399_CR56","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1098\/rspb.1995.0153","volume":"261","author":"A Goldbeter","year":"1995","unstructured":"Goldbeter A (1995) A model for circadian oscillations in the Drosophila period protein (PER). Proc Biol Sci 261(1362):319\u2013324","journal-title":"Proc Biol Sci"},{"issue":"9","key":"9399_CR57","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1073\/pnas.97.9.4649","volume":"97","author":"TM Yi","year":"2000","unstructured":"Yi TM, Huang Y, Simon MI, Doyle J (2000) Robust perfect adaptation in bacterial chemotaxis through integral feedback control. Proc Natl Acad Sci U S A 97(9):4649\u20134653","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9399_CR58","doi-asserted-by":"crossref","first-page":"0018","DOI":"10.3233\/ISB-00233","volume":"6","author":"P Gennemark","year":"2006","unstructured":"Gennemark P, Nordlander B, Hohmann S, Wedelin D (2006) A simple mathematical model of adaptation to high osmolarity in yeast. In Silico Biol 6:0018","journal-title":"In Silico Biol"},{"issue":"1","key":"9399_CR59","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cell.2009.04.047","volume":"138","author":"D Muzzey","year":"2009","unstructured":"Muzzey D, G\u00f3mez-Uribe CA, Mettetal JT, van Oudenaarden A (2009) A systems-level analysis of perfect adaptation in yeast osmoregulation. Cell 138(1):160\u2013171","journal-title":"Cell"},{"key":"9399_CR60","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1752-0509-7-131","volume":"7","author":"F He","year":"2013","unstructured":"He F, Fromion V, Westerhoff HV (2013) (Im)Perfect robustness and adaptation of metabolic networks subject to metabolic and gene-expression regulation: marrying control engineering with metabolic control analysis. BMC Syst Biol 7:131","journal-title":"BMC Syst Biol"},{"key":"9399_CR61","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1124\/jpet.107.133348","volume":"325","author":"WJ Thomsen","year":"2008","unstructured":"Thomsen WJ, Grottick AJ, Menzhagi F, Reyes-Saldana H, Espitia S, Yuskin D, Whelan K, Martin M, Morgan M, Chen W, Al-Shamma H, Smith B, Behan D (2008) Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization. J Pharmacol Exp Ther 325:577\u2013587","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"9399_CR62","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00213-002-1378-6","volume":"167","author":"SP Vickers","year":"2003","unstructured":"Vickers SP, Easton N, Webster LJ, Wyatt A, Bickerdike MJ, Dourish CT, Kennett GA (2003) Oral administration of the $$\\text{5-HT }_{2C}$$ 5-HT 2 C receptor agonist, $$m$$ m CPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia. Psychopharmacology (Berl) 167(3):274\u2013280","journal-title":"Psychopharmacology (Berl)"},{"key":"9399_CR63","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0140-6736(11)60812-X","volume":"378","author":"KD Hall","year":"2011","unstructured":"Hall KD (2011) Quantification of the effect of energy imbalance on bodyweight. Lancet 378:826\u2013837","journal-title":"Lancet"},{"key":"9399_CR64","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pharmthera.2009.03.002","volume":"122","author":"S Grimwood","year":"2009","unstructured":"Grimwood S, Hartig PR (2009) Target site occupancy: emerging generalizations from clinical and preclinical studies. Pharmacol Ther 122:281\u2013301","journal-title":"Pharmacol Ther"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-014-9399-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10928-014-9399-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-014-9399-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:07:43Z","timestamp":1747159663000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10928-014-9399-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,12]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["9399"],"URL":"https:\/\/doi.org\/10.1007\/s10928-014-9399-4","relation":{},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,12]]}}}